Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Not approved for human or veterinary administration
Giblin et al., Diabetes Obes Metab 2026 (trial design paper) Note: Some media reports cite NCT05869903 for TRIUMPH-4
It is also given to those seeking anti-aging benefits
Pregnancy Outcomes After Semaglutide Exposure
Unlike approved agents such as semaglutide (Wegovy) or tirzepatide (Zepbound), retatrutide has not yet received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for use in the United Kingdom
Investors are targeting discovery and platform-stage assets as long-term strategic bets to secure innovation pipelines for the next decade
US$ 22.96
US$ 21.95
US$ 20.24
US$ 28.36
US$ 22.80
